BRIEF-Tonix Pharma announces issuance of U.S. patent for TNX-102 SL composition and formulation
May 2 Tonix Pharmaceuticals Holding Corp
* Tonix pharmaceuticals announces issuance of u.s. Patent for tnx-102 sl composition and formulation designed for transmucosal absorption, bedtime daily use Source text for Eikon: Further company coverage:
BRIEF-Dimension Therapeutics updates on strategic review
* Dimension Therapeutics completes strategic review and updates corporate priorities
REFILE-US STOCKS-Futures slip on tech selloff; Yellen in focus
June 27 U.S. stock index futures were lower on Tuesday as a selloff in technology shares continued, while investors awaited clues on interest rate hikes from Federal Reserve Chair Janet Yellen's talk in London.